NORWELL, Mass., and ZÜRICH, Switzerland, July 01, 2025 (GLOBE NEWSWIRE) -- DIH HOLDING US, Inc. ("DIH") (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Rehazentrum Valens, a member of the Kliniken Valens ...

Revenue Performance - Revenue for Q3 2024 decreased by $3.9 million, or 20.6%, to $15.1 million from $19.0 million in Q3 2023[5] - Device revenue declined by 26% to $11.7 million, while service revenue grew by 4% to $3.1 million compared to the prior year[10] - Total revenue in the EMEA region decreased by 29% to $8.7 million, while revenue in the Americas decreased by 7% to $3.5 million[10] Profitability and Expenses - Gross profit for Q3 2024 was $7.2 million, a decrease of 30.4% year-over-year, primarily due to lower sales in the EMEA region[7] - Selling, general and administrative expenses increased by $2.8 million, or 50.6%, to $8.2 million, driven by higher employee compensation and overhead costs[8] - Research and development costs rose by $0.1 million, or 7.7%, to $1.8 million, mainly due to increased amortization expenses[9] - Net income for the three months ended December 31, 2025, was a loss of $3,728 thousand, compared to a profit of $2,969 thousand for the same period in 2024, representing a significant decline[23] - Comprehensive loss for the nine months ended December 31, 2024, was $6,496 thousand, compared to a loss of $2,616 thousand for the same period in 2023, indicating a worsening financial position[23] Cash Flow and Liquidity - Cash flows from operating activities for the nine months ended December 31, 2024, resulted in a net cash outflow of $848 thousand, compared to an inflow of $3,177 thousand for the same period in 2023[26] - Cash, cash equivalents, and restricted cash at the end of the period were $1,120 thousand, down from $1,679 thousand at the end of the previous year, indicating liquidity challenges[26] - Cash and cash equivalents totaled $1.1 million as of December 31, 2024[11] Equity and Financial Position - Total equity decreased to $(37,882) thousand as of December 31, 2024, from $(34,395) thousand as of September 30, 2024, indicating a decline in shareholder value[24] - The net transactions with the parent company resulted in an increase of $450 thousand in equity during the three months ended December 31, 2024[24] Asset Management - The company incurred depreciation and amortization expenses of $611 thousand for the nine months ended December 31, 2024, compared to $230 thousand for the same period in 2023, highlighting increased asset utilization[26] - The allowance for inventory obsolescence was $(67) thousand for the nine months ended December 31, 2024, a significant change from $705 thousand in the same period of 2023, suggesting improved inventory management[26] Future Outlook - The company reiterated its revenue guidance for fiscal year 2025, expecting a range between $60 million and $67 million[12] Collaborations - The company announced collaborations with Nobis Rehabilitation Partners and Zahrawi Group to expand its distribution network[10] Foreign Exchange Impact - The company reported a foreign exchange loss of $(241) thousand for the nine months ended December 31, 2024, compared to a gain of $181 thousand for the same period in 2023, reflecting adverse currency movements[26]

Core Insights - DIH Holding US, Inc. reported financial results for the third fiscal quarter ended December 31, 2024, showing a revenue decline of 20.6% year-over-year, primarily due to challenges in the EMEA region caused by import restrictions related to the Russia-Ukraine conflict [3][4][8] - The company reiterated its full-year revenue guidance for fiscal year 2025, maintaining a target range of $60 million to $67 million, despite current challenges [3][11] Financial Performance - Revenue for the third quarter was $15.1 million, down from $19.0 million in the same quarter of the previous year, with device sales decreasing by 25.6% to $11.7 million [4][8] - Gross profit decreased by 30.4% to $7.2 million, driven by lower sales volumes, while cost of sales decreased by 8.7% to $7.9 million [6][21] - Selling, general, and administrative expenses increased by 50.6% to $8.2 million, attributed to higher employee compensation and overhead costs [7][21] Regional Sales Performance - Revenue in the EMEA region decreased by 29% to $8.7 million, while revenue in the Americas decreased by 7% to $3.5 million [4][8] - The decline in EMEA sales was significantly impacted by wartime import restrictions affecting one of the company's largest sales partners in Eastern Europe [4][8] Partnerships and Future Outlook - The company has formed new partnerships with Nobis Rehabilitation Partners and Zahrawi Group, which are expected to enhance its distribution network and device integration capabilities [8] - Following a recent public offering that raised approximately $4.6 million, the company is positioned to meet order demand and support future growth initiatives [3][12] Cash Position - As of December 31, 2024, cash and cash equivalents totaled $1.1 million, a decrease from $3.2 million at the beginning of the period [10][28]

Core Viewpoint - DIH Holding US, Inc. has expanded its strategic partnership with Zahrawi Group to include Saudi Arabia, enhancing the distribution of advanced robotic rehabilitation devices across four countries in the Gulf region [1][3][4] Group 1: Company Overview - DIH is a global provider of advanced robotic devices for rehabilitation, focusing on patients with walking impairments, balance issues, and impaired arm and hand functions [1][5] - Zahrawi Group, established in 1989, is a leading medical devices and life science provider in the Gulf Cooperation Council, specializing in various healthcare solutions [2][6] Group 2: Partnership Expansion - The partnership aims to improve the accessibility of DIH's rehabilitation solutions, leveraging Zahrawi Group's established presence in the healthcare sector [3][4] - The collaboration will focus on delivering innovative technologies to enhance patient outcomes and support healthcare professionals [3][4] Group 3: Strategic Goals - The expanded partnership reflects both companies' commitment to innovation and high-quality rehabilitation solutions, aiming to make a significant impact on rehabilitation services in the Middle East [4]

Core Viewpoint - DIH Holding US, Inc. has successfully closed a public offering of 5,937,100 units at a price of $0.7832 per unit, aiming to enhance its capital for rehabilitation technology development [1][2]. Group 1: Offering Details - The offering consisted of units, each comprising one share of Class A common stock and one Class A warrant, with an exercise price of $0.7832 per share [1]. - The gross proceeds from the offering were approximately $4.6 million, which will be allocated for capital expenditures, working capital, and general corporate purposes [2]. Group 2: Company Overview - DIH is a global provider of advanced robotic devices for rehabilitation, focusing on patients with walking impairments, balance issues, and impaired arm and hand functions [5]. - The company aims to improve the lives of individuals with disabilities through innovative rehabilitation solutions, consolidating a fragmented industry [5].

Company Overview - DIH Holding US, Inc. is a global provider of advanced robotic devices for rehabilitation, focusing on patients with walking impairments, reduced balance, and impaired arm and hand functions [1][5] - The company aims to improve the daily lives of individuals with disabilities through innovative rehabilitation solutions [5] Public Offering Details - DIH announced a public offering of 5,937,100 units at a price of $0.7832 per unit, with each unit consisting of one share of Class A common stock and one Class A warrant [1] - The gross proceeds from the offering are expected to be approximately $4.6 million, which will be used for capital expenditures, working capital, and general corporate purposes [2] Securities Registration - The offering is conducted under a registration statement on Form S-1, which was declared effective by the SEC on January 31, 2025 [3] - A preliminary prospectus has been filed with the SEC, and electronic copies of the final prospectus will be available on the SEC's website [3] Placement Agent - Maxim Group LLC is acting as the sole placement agent for the offering [2]

NORWELL, Mass. and ALLEN, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced its new partnership with Nobis Rehabilitation Partners. This collaboration sign ...

Core Insights - DIH Holding US, Inc. has appointed Shepherd Center as a DIH Center of Excellence to enhance rehabilitation outcomes and drive advancements in rehabilitation technology [1][5] - The partnership aims to leverage DIH's advanced robotic devices and Shepherd Center's expertise in neurorehabilitation to improve patient recovery [5][6] Company Overview - DIH is a global provider of advanced robotic devices for rehabilitation, focusing on patients with walking impairments, balance issues, and impaired arm and hand functions [1][6] - The company aims to transform rehabilitation through innovative technology and has consolidated various niche technology providers in the industry [6] Shepherd Center Overview - Shepherd Center, based in Atlanta, Georgia, is recognized for its expertise in neurorehabilitation, specializing in complex conditions such as spinal cord injuries and brain injuries [3][7] - The center integrates state-of-the-art technology in its rehabilitation practices, enhancing clinical care and research [3][4] Technology Utilized - Shepherd Center employs various advanced rehabilitation devices, including Erigo®Pro for early mobilization, Lokomat®Pro for gait training, and C-Mill VR+ for balance evaluation [4] - The Armeo® product family is also utilized for arm and hand therapy, catering to a wide range of patient needs [4]

Core Insights - DIH Holding US, Inc. has designated Sheltering Arms Institute as a Center of Excellence, enhancing its collaboration with top-tier healthcare providers to improve patient recovery through innovative rehabilitation solutions [1][4] - The Center of Excellence program recognizes partners that exemplify best practices in rehabilitation robotics and demonstrate successful patient outcomes using DIH's therapy solutions [2] - Sheltering Arms Institute utilizes DIH's advanced robotic devices, including Erigo®Pro, Lokomat®Pro, Andago V2.0®, RYSEN, C-Mill VR+, Armeo®Power, and Armeo®Spring, to create personalized care plans for patients [3] Company Overview - DIH is a global provider of advanced robotic devices aimed at improving rehabilitation for individuals with disabilities and functional impairments, focusing on intensive rehabilitation and training [5] - The company has emerged as a transformative solutions provider in a fragmented industry through mergers with leading niche technology providers [5] Sheltering Arms Institute Overview - Sheltering Arms Institute is a non-profit physical rehabilitation hospital in Richmond, Virginia, recognized for its patient-centered care and ranked 1 in Virginia and 19 nationally by U.S. News & World Report [6] - The Institute integrates innovative treatment methodologies and cutting-edge technology to restore function and improve the quality of life for patients recovering from various conditions [6]

Revenue Performance - In the six months ended September 30, 2024, DIH generated revenue of $35.1 million, a 34.5% increase compared to $26.1 million in the same period of 2023[108] - Revenue for the three months ended September 30, 2024 increased by $5.1 million, or 39.1%, to $18.2 million from $13.1 million for the same period in 2023, primarily driven by a $4.9 million increase in device sales[128] - Devices revenue for the six months ended September 30, 2024 increased by $8.0 million, or 39.0%, to $28.6 million from $20.6 million for the same period in 2023[130] Profitability and Loss - DIH's net loss for the six months ended September 30, 2024, was $0.5 million, significantly improved from a net loss of $5.4 million in the prior year, driven by an $8.2 million increase in gross profit[109] - Operating income for the three months ended September 30, 2024 was $1.9 million, a significant improvement from an operating loss of $2.5 million in the same period of 2023[127] - Net loss for the three months ended September 30, 2024 was $234,000, a 90.6% improvement from a net loss of $2.5 million in the same period of 2023[127] Expenses and Costs - Selling, general and administrative expenses are projected to rise as DIH scales its workforce and enhances compliance with public company regulations[122] - Total operating expenses for the six months ended September 30, 2024 were $17.9 million, an increase of $2.7 million, or 17.7%, compared to $15.2 million for the same period in 2023[127] - Selling, general, and administrative expenses for the three months ended September 30, 2024 decreased by $0.6 million, or 9.6%, to $5.8 million compared to $6.4 million for the same period in 2023[135] - Research and development costs are expected to increase as DIH invests in product design and technology advancements[123] - Research and development costs for the three months ended September 30, 2024 increased by $0.3 million, or 20.6%, to $1.9 million from $1.6 million for the same period in 2023[137] Cash Flow and Liquidity - Cash and cash equivalents as of September 30, 2024 amounted to $1.8 million, down from $3.2 million as of March 31, 2024[143] - The company experienced negative cash flows from operating activities of $(1.5) million during the six months ended September 30, 2024[143] - Net cash used in operating activities increased by $3.3 million to $(1.5) million for the six months ended September 30, 2024, compared to $1.8 million for the same period in 2023[150] - Net cash provided by financing activities increased by $4.5 million to $0.8 million for the six months ended September 30, 2024, compared to $(3.7) million for the same period in 2023, primarily due to $2.8 million proceeds from convertible debt financing[151] - The company anticipates sources of liquidity to include cash on hand and cash flow from operations, while exploring financing alternatives in debt or equity[146] Business Developments - The business combination completed on February 7, 2024, included Hocoma Medical, enhancing DIH's asset base and operational capabilities[110] - DIH issued $3.3 million in principal amount of convertible debt on June 6, 2024, with net proceeds of approximately $2.8 million, convertible into 660,000 shares at a $5.00 per share conversion price[113] - The first redemption payment for the 8% Original Issue Discount Senior Secured Convertible Debentures was made in cash on November 1, 2024[145] Challenges and Outlook - DIH faces ongoing challenges from global supply chain disruptions and inflation, which may impact future operations and costs[114] - The transition to the EU MDR is expected to incur additional costs and complexities for DIH as it seeks to comply with new regulatory requirements[117] - DIH expects revenue to increase sequentially in future periods due to anticipated growth in demand for its rehabilitation products[119] - Cost of sales is expected to increase in absolute dollars as orders grow, but cost per unit is anticipated to decrease due to improved leverage[120] - The company continues to take steps to streamline its organization and cost structure to improve future revenue growth[146]